Skip to main content
Top
Published in: Neurological Sciences 1/2010

01-06-2010 | Chronic Migraine

Pathophysiology of migraine chronification

Authors: M. Aguggia, M. G. Saracco

Published in: Neurological Sciences | Special Issue 1/2010

Login to get access

Abstract

Migraine is a prevalent, disabling, undiagnosed and undertreated disease in neurological practice. It is a chronic, recurrent disorder with episodic manifestations that are progressive in some individuals with clinical, physiological and anatomical bases. Progression may be due to mechanisms generating the migraine attacks or to the activation generated by the attacks. Potentially remediable risk factors for chronification include frequency of migraine attacks, obesity, excessive use of medications, caffeine overuse, stressful life events, depression, sleep disorders and cutaneous allodynia.
Literature
1.
go back to reference Stewart WF, Shechter A, Lipton RB (1994) Migraine heterogeneity, disability, pain intensity, and attack frequency and duration. Neurology 44(Suppl 4):S24–S39PubMed Stewart WF, Shechter A, Lipton RB (1994) Migraine heterogeneity, disability, pain intensity, and attack frequency and duration. Neurology 44(Suppl 4):S24–S39PubMed
3.
go back to reference Scher AI, Migdette LA, Lipton RB (2008) Risk factors for headache chronification. Headache 48:16–25PubMedCrossRef Scher AI, Migdette LA, Lipton RB (2008) Risk factors for headache chronification. Headache 48:16–25PubMedCrossRef
4.
go back to reference Lipton RB (2009) Tracing transformation: chronic migraine classification, progression and epidemiology. Neurology 72(5 Suppl 1):S3–S7PubMedCrossRef Lipton RB (2009) Tracing transformation: chronic migraine classification, progression and epidemiology. Neurology 72(5 Suppl 1):S3–S7PubMedCrossRef
5.
go back to reference Welch KMA, Barkley GL, Tepley N et al (1993) Central neurogenic mechanisms of migraine. Neurology 43:S21–S25PubMed Welch KMA, Barkley GL, Tepley N et al (1993) Central neurogenic mechanisms of migraine. Neurology 43:S21–S25PubMed
6.
go back to reference Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine—current understanding and treatment. N Engl J Med 346:257–270PubMedCrossRef Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine—current understanding and treatment. N Engl J Med 346:257–270PubMedCrossRef
7.
go back to reference Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headache: a field study of revised HIS criteria. Neurology 47:871–875PubMed Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headache: a field study of revised HIS criteria. Neurology 47:871–875PubMed
8.
go back to reference (2004) Headache Classification Committee of the International Classification of Headache Disorders, 2nd edn. Cephalalgia (Suppl 1):1–160 (2004) Headache Classification Committee of the International Classification of Headache Disorders, 2nd edn. Cephalalgia (Suppl 1):1–160
9.
go back to reference Zwart JA, Dyb G, Hagen K, Swebak S, Holmen J (2003) Analgesic use: a predictor of chronic pain and medication overuse headache. Neurology 61:160–164PubMed Zwart JA, Dyb G, Hagen K, Swebak S, Holmen J (2003) Analgesic use: a predictor of chronic pain and medication overuse headache. Neurology 61:160–164PubMed
10.
go back to reference Limmroth V, Katsarava Z, Fritsche G et al (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59:1011–1014PubMed Limmroth V, Katsarava Z, Fritsche G et al (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59:1011–1014PubMed
11.
go back to reference Saper J (2002) Borderline personality disorder and the chronic headache patient: review and management recommendations. Headache 42:663–673PubMedCrossRef Saper J (2002) Borderline personality disorder and the chronic headache patient: review and management recommendations. Headache 42:663–673PubMedCrossRef
12.
go back to reference Mao J (2002) Opioid-induce abnormal pain sensitivity: implications in clinical practice. Pain 100:213–217PubMedCrossRef Mao J (2002) Opioid-induce abnormal pain sensitivity: implications in clinical practice. Pain 100:213–217PubMedCrossRef
13.
go back to reference Meng ID, Porreca F (2004) Basic science: mechanisms of medication overuse. Headache Curr 1:47–54CrossRef Meng ID, Porreca F (2004) Basic science: mechanisms of medication overuse. Headache Curr 1:47–54CrossRef
14.
go back to reference Lipton RB, Bigal ME (2008) Looking to the future: research designs for study of headache disease progression. Headache 48:58–66PubMedCrossRef Lipton RB, Bigal ME (2008) Looking to the future: research designs for study of headache disease progression. Headache 48:58–66PubMedCrossRef
15.
go back to reference Granziera C, DaSilva AF, Snyder J, Tuch DS, Hadjikhani N (2006) Anatomical alterations of the visual motion processing network in migraine with and without aura. PLoS Med 3:e402PubMedCrossRef Granziera C, DaSilva AF, Snyder J, Tuch DS, Hadjikhani N (2006) Anatomical alterations of the visual motion processing network in migraine with and without aura. PLoS Med 3:e402PubMedCrossRef
16.
go back to reference Ambrosini A, Rossi P, De Pasqua V, Pierelli F, Schoenen J (2003) Lack of habituation causes high intensity dependence of auditory evoked cortical potentials in migraine. Brain 126:2009–2015PubMedCrossRef Ambrosini A, Rossi P, De Pasqua V, Pierelli F, Schoenen J (2003) Lack of habituation causes high intensity dependence of auditory evoked cortical potentials in migraine. Brain 126:2009–2015PubMedCrossRef
17.
go back to reference Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF (2000) Migraine, quality of life, and depression: a population-based case–control study. Neurology 55:629–635PubMed Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF (2000) Migraine, quality of life, and depression: a population-based case–control study. Neurology 55:629–635PubMed
18.
go back to reference Haut SR, Bigal ME, Lipton RB (2006) Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol 5:148–157PubMedCrossRef Haut SR, Bigal ME, Lipton RB (2006) Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol 5:148–157PubMedCrossRef
19.
go back to reference Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 47:871–875PubMed Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 47:871–875PubMed
20.
21.
go back to reference Welch KM, Goadsby PJ (2002) Chronic daily headache: nosology and pathophysiology. Curr Opin Neurol 15:287–295PubMedCrossRef Welch KM, Goadsby PJ (2002) Chronic daily headache: nosology and pathophysiology. Curr Opin Neurol 15:287–295PubMedCrossRef
22.
go back to reference Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106:81–89PubMedCrossRef Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106:81–89PubMedCrossRef
23.
go back to reference Lipton RB, Bigal ME, Diamond M et al (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68:343–349PubMedCrossRef Lipton RB, Bigal ME, Diamond M et al (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68:343–349PubMedCrossRef
24.
go back to reference Boardman HF, Thomas E, Millson DS, Croft PR (2006) The natural history of headache: predictors of onset and recovery. Cephalalgia 26:1080–1088PubMedCrossRef Boardman HF, Thomas E, Millson DS, Croft PR (2006) The natural history of headache: predictors of onset and recovery. Cephalalgia 26:1080–1088PubMedCrossRef
25.
go back to reference Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH (2000) An association between migraine and cutaneous allodynia. Ann Neurol 47:614–624PubMedCrossRef Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH (2000) An association between migraine and cutaneous allodynia. Ann Neurol 47:614–624PubMedCrossRef
26.
go back to reference Kruit MC, van Buchem MA, Hofman PA et al (2004) Migraine as a risk factor for subclinical brain lesions. JAMA 291:427–434PubMedCrossRef Kruit MC, van Buchem MA, Hofman PA et al (2004) Migraine as a risk factor for subclinical brain lesions. JAMA 291:427–434PubMedCrossRef
27.
go back to reference Ashkenazi A, Silberstein S, Jakubowski M, Burstein R (2007) Improved identification of allodynic migraine patients using a questionnaire. Cephalalgia 27:325–329PubMedCrossRef Ashkenazi A, Silberstein S, Jakubowski M, Burstein R (2007) Improved identification of allodynic migraine patients using a questionnaire. Cephalalgia 27:325–329PubMedCrossRef
28.
go back to reference Burstein R, Cutrer MF, Yarnitsky D (2000) The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 123:1703–1709PubMedCrossRef Burstein R, Cutrer MF, Yarnitsky D (2000) The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 123:1703–1709PubMedCrossRef
29.
go back to reference Knight YE, Goadsby PJ (2001) The periaqueductal gray matter modulates trigeminovascular input: a role in migraine? Neuroscience 106:793–800PubMedCrossRef Knight YE, Goadsby PJ (2001) The periaqueductal gray matter modulates trigeminovascular input: a role in migraine? Neuroscience 106:793–800PubMedCrossRef
30.
go back to reference Hoskin KL, Bulmer DCE, Lasalandra M, Jonkman A, Goadsby PJ (2001) Fos expression in the midbrain periaqueductal grey after trigeminovascular stimulation. J Anat 197:29–35CrossRef Hoskin KL, Bulmer DCE, Lasalandra M, Jonkman A, Goadsby PJ (2001) Fos expression in the midbrain periaqueductal grey after trigeminovascular stimulation. J Anat 197:29–35CrossRef
31.
go back to reference Welch KMA, Nagesh V, Aurora SK, Gelman N (2001) Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41:629–637PubMedCrossRef Welch KMA, Nagesh V, Aurora SK, Gelman N (2001) Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41:629–637PubMedCrossRef
32.
33.
go back to reference Moskowitz MA, Kurth T (2007) Blood vessels, migraine, and stroke. Stroke 63:148–158 Moskowitz MA, Kurth T (2007) Blood vessels, migraine, and stroke. Stroke 63:148–158
Metadata
Title
Pathophysiology of migraine chronification
Authors
M. Aguggia
M. G. Saracco
Publication date
01-06-2010
Publisher
Springer Milan
Published in
Neurological Sciences / Issue Special Issue 1/2010
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-010-0264-y

Other articles of this Special Issue 1/2010

Neurological Sciences 1/2010 Go to the issue

Posters

Posters